A9607 — Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
What the market charges
Across 865 negotiated rates, the middle 80% fall between $52 and $570, with a median of $269.
What Medicare pays
Medicare allowed an average of $255 for this code, across 301,011 services billed by 31 providers. At the median, the market charges about what Medicare pays for this code.
Where this is billed, and what it costs there
The states billing A9607 most, by Medicare service volume, each compared against the national average of $255. Each links to the providers Mishe lists there.
- Arizona — 8 providers billed it, Medicare allowed $254 — level with the national average
Other codes
- J2777 — Injection, faricimab-svoa, 0.1 mg
- J0897 — Injection, denosumab, 1 mg
- J9271 — Injection, pembrolizumab, 1 mg
- J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- G0008 — Administration of influenza virus vaccine
- G0439 — Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9299 — Injection, nivolumab, 1 mg
- J1745 — Injection, infliximab, excludes biosimilar, 10 mg
- J2357 — Injection, omalizumab, 5 mg
Deploy this for your team
Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.
- Contact Mishe to learn how to deploy these resources for your team
- Guides to direct-pay healthcare
- Cash prices by procedure
- Find a provider by state
Take back healthcare.